Log In
Print
BCIQ
Print
Print this Print this
 

ATX-101

  Manage Alerts
Collapse Summary General Information
Company Kythera Biopharmaceuticals Inc.
DescriptionSynthetic sodium deoxycholate for injection
Molecular Target Undisclosed
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationBody Fat
Indication DetailsReduce submental (under chin) fat; Treat lipoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today